Fri, October 21, 2022
Thu, October 20, 2022
Wed, October 19, 2022

Joseph Schwartz Maintained (TVTX) at Buy with Decreased Target to $38 on, Oct 20th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-38-on-oct-20th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Schwartz of SVB Leerink, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $45 to $38 on, Oct 20th, 2022.

Joseph has made no other calls on TVTX in the last 4 months.



There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joseph


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $36 on, Monday, October 17th, 2022
  • Do Kim of "Piper Sandler" Maintained at Buy with Decreased Target to $38 on, Friday, October 14th, 2022
  • Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $42 on, Thursday, July 14th, 2022

Publication Contributing Sources